Contents
Managing a chronic condition often involves much more than responding to symptoms. It may require regular medical visits, medication review, lifestyle support, home measurements, and laboratory testing that shows how the body is functioning over time.
The Centers for Disease Control and Prevention broadly defines a chronic disease as a condition lasting at least one year that requires ongoing medical attention, limits daily activities, or both. Current CDC data indicate that approximately three in four American adults report at least one chronic condition, while more than half report two or more.
Laboratory tests can provide objective information about blood sugar, cholesterol, blood cells, kidney filtration, liver enzymes, thyroid hormones, inflammation, nutritional status, and medication safety. They may help identify changes before symptoms become obvious and show whether a condition is stable, improving, or worsening.
However, laboratory testing does not provide a complete picture by itself. Results should be interpreted alongside symptoms, medical history, medications, physical examinations, home measurements, imaging, and other clinical information.
Ulta Lab Tests provides access to many blood and urine tests that patients can order online where available. Testing is informational and does not replace evaluation, diagnosis, or treatment from a qualified healthcare professional.
Chronic disease management is the coordinated, long-term process of monitoring a persistent health condition, reducing avoidable risks, assessing response to care, and identifying complications that may require medical attention.
Common chronic conditions include:
Some people live with several conditions at the same time. This is sometimes called multiple chronic conditions or multimorbidity. One condition may influence another. Diabetes and hypertension, for example, may affect kidney and cardiovascular health, while kidney or liver impairment may affect how certain medications are processed.
Effective management therefore focuses on the whole person rather than viewing each laboratory value in isolation.
Direct answer: Managing chronic conditions means regularly reviewing symptoms, medications, lifestyle factors, home measurements, and appropriate laboratory results so patients and healthcare providers can recognize meaningful changes and make informed care decisions.
Chronic conditions may develop gradually and remain relatively silent for years. High cholesterol, early kidney disease, hypertension, and elevated blood glucose may cause few noticeable symptoms until complications develop.
Ongoing monitoring can help patients and clinicians:
Laboratory monitoring is especially valuable when symptoms are nonspecific. Fatigue, weakness, weight change, swelling, pain, and difficulty concentrating may arise from many different causes. A laboratory result may provide a useful clue, but it should not automatically be assumed to explain the symptom.
| Symptom or Risk Factor | What It May Suggest | Related Lab Tests |
|---|---|---|
| Persistent fatigue or weakness | Anemia, blood sugar changes, thyroid dysfunction, kidney or liver problems, or nutritional deficiency | CBC with Differential and Platelets, CMP, A1c, Glucose, TSH, Free T4, Ferritin, Ferritin, Iron and TIBC Panel, Vitamin B12 |
| Increased thirst or urination | Elevated blood glucose, medication effects, or fluid and electrolyte imbalance | Glucose Test, A1c Test, CMP, Urinalysis Complete Test |
| Swelling in the legs or around the eyes | Kidney, liver, cardiovascular, or protein-balance concerns | CMP, Creatinine Test, Kidney Profile, Albumin Random Urine Test with Creatinine, Urinalysis Complete Test |
| Unexplained weight change or temperature sensitivity | Thyroid, metabolic, medication, or nutritional concerns | TSH Test, Free T4 Test, Glucose Test, A1c Test, CMP |
| Foamy urine or changes in urination | Protein in urine, urinary tract problems, or kidney dysfunction | Urinalysis Complete Test, Albumin Random Urine Test with Creatinine, Kidney Profile |
| Easy bruising, pallor, or recurrent infections | Blood-cell, platelet, nutritional, medication, or immune concerns | CBC with Differential and Platelets, CMP, Ferritin, Iron and TIBC Panel, condition-specific testing |
| Joint pain or prolonged stiffness | Inflammatory, autoimmune, degenerative, or metabolic causes | C-Reactive Protein Test, Sed Rate Test, CBC, CMP, and targeted autoimmune tests when indicated |
| Numbness or tingling | Diabetes, vitamin deficiency, thyroid dysfunction, medication effects, or neurological disease | Glucose Test, A1c Test, Vitamin B12 Test, TSH Test, CMP |
| Jaundice, dark urine, or abdominal swelling | Liver, bile-duct, blood-cell, or other medical problems | Hepatic Function Panel, GGT Test, CBC, CMP |
| Chest pressure or sudden shortness of breath | Potential heart, lung, clotting, or other emergency | Immediate medical evaluation—not routine direct-access testing |
Safety note: Call 911 or seek urgent medical care for chest pain, severe breathing difficulty, sudden weakness, confusion, fainting, signs of stroke, vomiting blood, black stools, severe dehydration, or rapidly worsening symptoms.
Laboratory tests can answer important but limited questions.
Testing may provide information about:
A laboratory test generally cannot:
An isolated result is a data point—not a complete diagnosis.
The following tests may be used in chronic disease evaluation or monitoring. Not everyone needs every test.
| Lab Test or Biomarker | What It Measures | Why It May Be Relevant | What Abnormal Results May Generally Suggest | Important Limitations |
|---|---|---|---|---|
| Complete Blood Count with Differential and Platelets | Red cells, hemoglobin, white cells, and platelets | Helps evaluate anemia, infection patterns, blood-cell abnormalities, and some medication effects | Low hemoglobin may occur with anemia; abnormal white cells or platelets have many possible causes | Does not identify the cause of an abnormal blood count by itself |
| Comprehensive Metabolic Panel | Glucose, electrolytes, kidney markers, proteins, calcium, and several liver-related markers | Provides a broad view of metabolic and organ function | High or low results may reflect kidney, liver, glucose, hydration, electrolyte, or protein-balance concerns | Individual components must be interpreted together and in context |
| Glucose Test | Blood glucose at one point in time | Used in diabetes and metabolic evaluation | Elevated glucose may reflect diabetes, prediabetes, stress, illness, or medication effects | A single result may need confirmation |
| A1c Test | Approximate average glucose exposure over two to three months | Commonly used to evaluate longer-term glucose control | Higher values generally reflect greater average glucose exposure | Certain blood disorders, pregnancy, kidney disease, blood loss, or transfusion may affect interpretation |
| Lipid Panel Test | Total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides | Helps assess cardiovascular risk and response to cholesterol management | High LDL or triglycerides may be associated with increased cardiovascular risk | Overall risk also depends on age, blood pressure, diabetes, smoking, family history, and other factors |
| Apolipoprotein B Test | The concentration of ApoB-containing atherogenic particles | May add information when triglycerides are high or LDL cholesterol does not fully reflect particle burden | Higher ApoB generally indicates more potentially harmful particles | Not required for every patient |
| Lipoprotein(a) Test | A mostly inherited lipoprotein | May identify an inherited source of cardiovascular risk not shown on a standard lipid panel | Higher levels are associated with greater cardiovascular risk | Usually changes little over time and must be interpreted with total risk |
| Creatinine Test and Kidney Profile | Creatinine and estimated kidney filtration; the Kidney Profile also includes urine albumin assessment | Helps evaluate and monitor kidney function | Higher creatinine or lower estimated filtration may reflect reduced kidney filtration | Age, muscle mass, hydration, acute illness, and other factors may affect results |
| Albumin Random Urine Test with Creatinine | Albumin relative to creatinine in urine | Detects urine protein that may be an early marker of kidney damage | Persistent elevation may indicate kidney damage and greater kidney or cardiovascular risk | Exercise, fever, infection, menstruation, and temporary illness may affect results; confirmation is often needed |
| Hepatic Function Panel | ALT, AST, alkaline phosphatase, bilirubin, albumin, and related markers | Helps evaluate liver-cell injury, bile flow, and liver protein production | Abnormal patterns may suggest liver, bile-duct, bone, medication, or other concerns | No single liver marker identifies the cause |
| TSH and Free T4 Test | Thyroid-stimulating hormone and free thyroxine | Commonly used to evaluate and monitor thyroid function | High or low patterns may suggest underactive or overactive thyroid function | Illness, pregnancy, medications, supplements, and timing may affect interpretation |
| C-Reactive Protein Test or hs-CRP Test | Proteins associated with inflammation | CRP may support evaluation of inflammatory activity; hs-CRP may add cardiovascular-risk information in selected patients | Higher results indicate inflammation but not its source | Infection, injury, obesity, smoking, and many conditions can raise CRP |
| Sed Rate Test | An indirect marker affected by inflammation and blood characteristics | May help follow certain inflammatory conditions | Higher results may occur with inflammation, anemia, infection, or other conditions | Nonspecific and not diagnostic |
| Ferritin, Iron and Total Iron Binding Capacity Panel | Stored iron and circulating iron-related measures | Useful when fatigue, anemia, blood loss, malabsorption, or iron excess is a concern | Low ferritin often suggests reduced iron stores; high ferritin may occur with inflammation or iron overload | Ferritin can rise during inflammation and should be interpreted with other iron results |
| Vitamin B12 and Folate Panel Test | Vitamin B12 and folate levels | May be appropriate with anemia, neurological symptoms, restrictive diets, or malabsorption risks | Low results may support deficiency evaluation | Results should be interpreted with symptoms, blood counts, medications, and other testing when needed |
| Vitamin D 25-Hydroxy Total Test | Circulating 25-hydroxyvitamin D | May be appropriate with bone-health concerns, known deficiency, malabsorption, or selected risk factors | Low results may indicate inadequate vitamin D status | Routine broad vitamin testing is not necessary for everyone |
| Urinalysis Complete Test | Cells, protein, glucose, blood, concentration, and other urine findings | May provide information about urinary, kidney, metabolic, or hydration concerns | Abnormal findings have many possible causes | Contamination and temporary conditions may affect results |
| Medication-specific monitoring | Drug levels or possible effects on blood counts, kidney function, liver function, electrolytes, or coagulation | Certain medicines require scheduled safety monitoring | Results may indicate a need for clinician review | Never change a medication dose based on a self-interpreted result |
Common tests may include:
A1c provides a longer-term view of glucose exposure, while a glucose test measures the level at the time of collection. Kidney and cardiovascular markers are also important because diabetes can affect more than blood sugar.
Testing may include:
Blood pressure measurements, smoking history, family history, medications, and clinical risk calculations remain essential. A blood test does not replace blood-pressure monitoring, electrocardiography, imaging, or evaluation of symptoms.
Testing may include:
An estimated filtration result below the expected range does not necessarily establish chronic kidney disease from a single sample. Chronicity, urine findings, age, health history, and repeat testing matter.
Typical monitoring may include:
TSH is frequently the primary monitoring test, but the appropriate combination depends on the condition, medication, pregnancy status, symptoms, and clinical history.
Testing may include:
Liver tests are best interpreted as patterns. An abnormal enzyme, bilirubin, albumin, or protein result may have several possible explanations.
Possible monitoring tests include:
Broad autoimmune screening without a clinical reason may produce confusing positive results. Autoantibodies should be selected and interpreted according to symptoms, examination findings, and the suspected condition.
A focused starting evaluation may include:
Testing should be guided by the symptom pattern rather than by ordering every available hormone, vitamin, or autoimmune test.
Essential testing establishes a focused baseline using tests that are directly related to the diagnosed condition or major risk factor.
Advanced testing may be considered when routine results do not fully answer the clinical question.
A broader evaluation may be appropriate when a person has:
Comprehensive testing should still be purposeful. More testing is not automatically better testing.
Follow-up tests may be used to:
Testing frequency should be individualized by a qualified healthcare professional. It may vary according to the condition, severity, medication, previous results, age, pregnancy status, and recent changes in health.
A reference range represents values found in a defined comparison population. It is not a universal dividing line between healthy and unhealthy.
A result outside the range may be temporary or may not be clinically significant. A result inside the range does not guarantee that a condition is absent.
The term “optimal” is often used online, but it does not have one standardized meaning for every test. Clinical targets may differ according to diagnosed conditions, age, pregnancy, cardiovascular risk, kidney function, medications, and professional guidelines.
A gradual change across several results may be more informative than one isolated value. When possible, compare results performed using the same laboratory and method because ranges and analytical methods may differ.
For example, an abnormal creatinine result may be interpreted with estimated filtration, prior results, hydration, medications, urine protein, age, and muscle mass. An elevated liver enzyme may be reviewed with other liver markers, symptoms, medications, alcohol use, infection risk, and imaging.
Testing may be worth discussing when:
Direct-access testing should not delay medical care for new, severe, or rapidly changing symptoms.
Preparation depends on the specific test.
Some glucose and lipid tests may require fasting, while the A1c Test generally does not. Preparation requirements vary, so the instructions for the specific test should always take priority.
Ulta Lab Tests gives patients access to many laboratory tests that can be ordered directly online where available. Patients can review test options and transparent prices before ordering without using insurance.
Specimen collection is performed through established laboratory networks such as Quest Diagnostics where applicable. Results are delivered securely online and can be used to support more informed conversations with a qualified healthcare professional.
HSA or FSA payment may be available for eligible purchases where accepted. Patients can explore testing through related health areas, including General Health Tests, Diabetes Tests, Heart and Cardiovascular Tests, Kidney Tests, Liver Tests, Thyroid Tests, Inflammation Tests, and Vitamin and Mineral Tests.
Laboratory access does not mean every available test is necessary. The most useful approach is to select tests that answer a defined health question and review the results with a clinician who understands your complete medical history.
Common tests include a CBC with Differential and Platelets, Comprehensive Metabolic Panel, A1c Test, Glucose Test, Lipid Panel Test, kidney tests, liver tests, thyroid tests, and selected urine tests. The appropriate combination depends on the condition being monitored and the person’s medications, symptoms, and risk factors.
Some tests contribute directly to diagnostic criteria, but many provide supportive rather than definitive information. A diagnosis may require repeat testing, symptoms, medical history, physical examination, imaging, or other procedures. Broad panels such as a CBC or CMP may identify abnormalities, but they usually do not establish the cause without further evaluation.
There is no single schedule for every patient. Frequency depends on the condition, previous results, medications, treatment changes, pregnancy status, symptom changes, and complication risk. Stable conditions may require less frequent testing than newly diagnosed or changing conditions. A healthcare provider should establish the monitoring schedule.
The A1c Test is frequently used to estimate average glucose exposure over approximately two to three months. The Glucose Test provides a measurement at one point in time. A Kidney Profile, Albumin Random Urine Test with Creatinine, and Lipid Panel Test may also be relevant because diabetes can affect several body systems.
Central kidney measurements include creatinine with estimated filtration and urine albumin relative to creatinine. The Kidney Profile combines common blood and urine kidney markers, while the Albumin Random Urine Test with Creatinine evaluates urine protein. Electrolytes, a Urinalysis Complete Test, and a CBC may also be used.
No. The C-Reactive Protein Test, hs-CRP Test, and Sed Rate Test are nonspecific markers. They may support the evaluation or monitoring of selected conditions, but they do not identify the source of inflammation. Infection, injury, obesity, smoking, anemia, and many other factors can influence the results.
Not always. Some conditions fluctuate, remain localized, or do not produce abnormalities on routine blood testing. A result within the reference range also does not guarantee that the value is appropriate for every individual. Persistent symptoms should be discussed with a healthcare provider even when initial laboratory results appear normal.
Ulta Lab Tests allows patients to order many blood and urine tests online where available. Direct access can be useful for obtaining baseline or follow-up information. However, it does not replace professional medical evaluation, and direct-access results should not be used to independently diagnose a condition or change medication.
Many abnormal results require confirmation, particularly when a finding is unexpected or could have been influenced by illness, hydration, exercise, fasting, medication, or specimen collection. The urgency and timing of repeat testing depend on the result and symptoms. Markedly abnormal or critical results require prompt professional review.
No medication should be started, stopped, or adjusted solely on the basis of self-interpreted laboratory results. Medication decisions may require consideration of symptoms, diagnosis, kidney and liver function, interactions, side effects, blood pressure, physical examination, and other health information. Contact the prescribing clinician for guidance.
Chronic disease management works best when symptoms, laboratory findings, home measurements, medications, and professional medical care are considered together.
Focused blood and urine testing can help establish a baseline, reveal meaningful changes, monitor organ function, and support safer conversations about diabetes, cardiovascular risk, kidney health, liver health, thyroid function, inflammation, nutrition, and medication safety.
Ulta Lab Tests offers convenient access to many relevant tests with online ordering, transparent pricing, established laboratory collection networks, and secure online results. Explore chronic disease blood tests and general health testing, and review your results with a qualified healthcare professional who can interpret them in the context of your complete health history.
Medical disclaimer: Laboratory testing provides information. It does not replace medical diagnosis, individualized treatment, or urgent care when serious symptoms occur.
Definition: Chronic disease management is the ongoing process of monitoring and coordinating care for a health condition that lasts at least one year or requires continuing medical attention. Laboratory tests provide objective information that may help track disease activity, organ function, cardiovascular risk, nutritional status, and medication safety.
Related laboratory tests: CBC with Differential and Platelets, CMP, Glucose, A1c, Lipid Panel, ApoB, Lipoprotein(a), Kidney Profile, Urine Albumin-Creatinine Testing, Hepatic Function Panel, TSH and Free T4, CRP, Sed Rate, Iron Studies, Vitamin B12 and Folate, Vitamin D, and Urinalysis.
How Ulta Lab Tests helps: Ulta Lab Tests provides direct online access to many relevant blood and urine tests where available, with transparent pricing and secure online results.
Disclaimer: Laboratory testing is informational and should be reviewed with a qualified healthcare provider.
Medication monitoring does not refer to one universal panel. The appropriate blood count, metabolic, kidney, liver, electrolyte, coagulation, or drug-level test depends on the medication and the prescribing healthcare provider’s instructions. Explore Medication Lab Monitoring.
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
